CD2AP and colonic neoplasm: Low CD2AP expression has been associated with poor prognosis in gastric cancer and renal clear cell carcinoma patients, and its reduction in vitro triggers unfavorable partial EMT processes in colon cancer cells (Xie et al., 2020; Kurilla et al., 2023; Chen et al., 2024).